Table 1.
Age, sex, and sector of contacts of non-institutionalized primary Beta cases by vaccination status,* Israel, Dec 11, 2020 – Mar 25, 2021. (N=343^)
| Fully-Vaccinated (n=31) | Partially-vaccinated (n=32) | Initially-Vaccinated(n=34) | Unvaccinated (n=246) | Total (n=343) | |
|---|---|---|---|---|---|
| Age (median, range) | |||||
| Years | 58 (21 – 87) | 38 (18 – 72) | 40 (16 –57) | 39 (16 – 94) | 40 (16 – 94) |
| Sex (n, percent) | |||||
| Male | 14 (45) | 12 (37) | 19 (56) | 108 (44) | 153 (45) |
| Female | 17 (55) | 20 (62) | 15 (44) | 138 (56) | 190 (55) |
| Sector (n, percent) | |||||
| Arab | 8 (26) | 13 (41) | 13 (38) | 74 (30) | 108 (31) |
| Ultra-orthodox | 1 (3) | 1 (3) | 0 (0) | 4 (2) | 6 (2) |
| General Jewish (non-ultra-orthodox) | 22 (71) | 18 (47) | 21 (62) | 168 (68) | 229 (67) |
* Vaccination status: Fully-vaccinated = received two doses of BNT162b2 ≥7 days after the second dose. Initially-vaccinated = received one dose of BNT162b2 <14 days after the first dose. Partially-vaccinated = received one dose of BNT162b2 ≥14 days after the first dose or two doses <7 days after the second dose. Unvaccinated = never received BNT162b2.
^Seven contacts were exposed to an additional infectious primary Beta case, resulting in 350 exposure events in the cohort analysis. The median age of the seven contacts with exposure to two cases was 31 years (range 26-87); 1/7 (14%) were male. The vaccination history was 2/7 (28%) fully-vaccinated, 3 (43%) initially-vaccinated, 0 partially-vaccinated, and 2 (28%) unvaccinated